Silo Pharma, Inc.
SILO
$0.7261
-$0.053-6.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Cost of Revenue | 6.00K | 6.00K | 5.90K | 5.90K | 5.90K |
| Gross Profit | 66.40K | 66.40K | 66.40K | 66.40K | 66.40K |
| SG&A Expenses | 2.41M | 2.47M | 2.56M | 2.66M | 3.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.99M | 4.78M | 4.13M | 3.89M | 4.00M |
| Operating Income | -4.92M | -4.71M | -4.06M | -3.82M | -3.93M |
| Income Before Tax | -4.62M | -4.39M | -3.71M | -3.45M | -3.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.62 | -4.39 | -3.71 | -3.45 | -3.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.62M | -4.39M | -3.78M | -3.51M | -3.60M |
| EBIT | -4.92M | -4.71M | -4.06M | -3.82M | -3.93M |
| EBITDA | -3.91M | -2.82M | -1.01M | -- | -- |
| EPS Basic | -1.14 | -1.19 | -1.18 | -1.18 | -1.19 |
| Normalized Basic EPS | -0.71 | -0.74 | -0.72 | -0.72 | -0.73 |
| EPS Diluted | -1.14 | -1.19 | -1.18 | -1.18 | -1.19 |
| Normalized Diluted EPS | -0.71 | -0.74 | -0.72 | -0.72 | -0.73 |
| Average Basic Shares Outstanding | 16.33M | 14.71M | 13.30M | 12.11M | 12.21M |
| Average Diluted Shares Outstanding | 16.33M | 14.71M | 13.30M | 12.11M | 12.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |